Skip to main content
Erschienen in: Breast Cancer 2/2018

12.10.2017 | Rapid Communication

Trends in the clinical stage distribution of breast cancer in Osaka, Japan

verfasst von: Yasuhiro Toyoda, Takahiro Tabuchi, Tomio Nakayama, Shigeyuki Hojo, Setsuko Yoshioka, Yukiko Wakabayashi, Yoshiichi Maeura

Erschienen in: Breast Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

We examined the proportion of screen-detected breast cancer cases and clinical stage distribution by age group among female breast cancer cases in Osaka, Japan using population-based cancer registry from the period 1980 to 2012. The proportion of local cases increased and that of regional cases decreased gradually during the study period. The proportion of distant cases leveled off. The proportion of in situ cases increased rapidly after 2003. This increase was noticeable for women aged 30–39, 40–49, 50–59, and 60–69 years. The proportion of in situ cases for women aged 40–49, 50–59, and 60–69 years reached 15.4, 11.3, and 9.9% in 2010–2012, respectively. Regarding screening status, the proportion of screen-detected cases before 1988 was under 3%. Between 1989 and 2003, it leveled off at around 5%. After 2003, the proportion increased noticeably, and reached 25.4%:34.0% in aged 40–49 years, 32.8% in aged 50–59 years, and 26.7% in aged 60–69 years. The increase in local cases and decrease in regional cases would be due to awareness of breast cancer, probably a result of developments in medical diagnostic technology. On the other hand, the steep increase of in situ cases might be due to screening. We need careful monitoring of the trends in breast cancer incidence by clinical stage.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am. 2004;42:793–806.CrossRefPubMed Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am. 2004;42:793–806.CrossRefPubMed
3.
Zurück zum Zitat Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995;75:1619–26.CrossRefPubMed Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995;75:1619–26.CrossRefPubMed
5.
Zurück zum Zitat Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989;59:954–8.CrossRefPubMedPubMedCentral Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989;59:954–8.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Chu KC, Kramer BS, Smart CR. Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst. 1991;83:1636–43.CrossRefPubMed Chu KC, Kramer BS, Smart CR. Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst. 1991;83:1636–43.CrossRefPubMed
7.
Zurück zum Zitat Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.CrossRefPubMed Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.CrossRefPubMed
8.
Zurück zum Zitat Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–47.CrossRefPubMed Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–47.CrossRefPubMed
9.
Zurück zum Zitat Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.CrossRefPubMed Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.CrossRefPubMed
10.
Zurück zum Zitat Toyoda Y, Tabuchi T, Nakayama T, Hojo S, Yoshioka S, Maeura Y. Past trends and future estimation of annual breast cancer incidence in Osaka, Japan. Asian Pac J Cancer Priv. 2016;17:2847–52. Toyoda Y, Tabuchi T, Nakayama T, Hojo S, Yoshioka S, Maeura Y. Past trends and future estimation of annual breast cancer incidence in Osaka, Japan. Asian Pac J Cancer Priv. 2016;17:2847–52.
11.
Zurück zum Zitat Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 6, 1987 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 6, 1987 (in Japanese).
12.
Zurück zum Zitat Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 20, 1995 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 20, 1995 (in Japanese).
13.
Zurück zum Zitat Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 34, 2005 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 34, 2005 (in Japanese).
14.
Zurück zum Zitat Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 43, 2016 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 43, 2016 (in Japanese).
15.
Zurück zum Zitat Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of monitoring and evaluation system. Br J Cancer. 1989;59:954–8.CrossRefPubMedPubMedCentral Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of monitoring and evaluation system. Br J Cancer. 1989;59:954–8.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Osaka Prefectural Department of Environment and Public Health, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 45, Cancer Incidence and Medical Care in Osaka in 1985, 1988 (in Japanese). Osaka Prefectural Department of Environment and Public Health, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 45, Cancer Incidence and Medical Care in Osaka in 1985, 1988 (in Japanese).
17.
Zurück zum Zitat Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 80, Cancer Incidence and Medical Care in Osaka in 2011–2012 and the Survival in 2009, 2016 (in Japanese). Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 80, Cancer Incidence and Medical Care in Osaka in 2011–2012 and the Survival in 2009, 2016 (in Japanese).
Metadaten
Titel
Trends in the clinical stage distribution of breast cancer in Osaka, Japan
verfasst von
Yasuhiro Toyoda
Takahiro Tabuchi
Tomio Nakayama
Shigeyuki Hojo
Setsuko Yoshioka
Yukiko Wakabayashi
Yoshiichi Maeura
Publikationsdatum
12.10.2017
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 2/2018
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0807-7

Weitere Artikel der Ausgabe 2/2018

Breast Cancer 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.